Progress with transcatheter tricuspid valve replacement (TTVR) candidate devices Topaz, LuX-Valve Plus, VDyne, and Trisol for ...

SOMERSET, N.J., May 22, 2025 (GLOBE NEWSWIRE ... will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting and the 2025 European Hematology Association ...

SOMERSET, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ ... myeloma will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting and the 2025 ...

“We are very encouraged by these remarkable results and the fact that they are being presented in two of the most prestigious platforms in oncology research – the ASCO Annual Meeting and ...

May 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, announced today that new data will be presented at the 2025 American Society of Clinical ...

LOS ANGELES, CA, May 21, 2025 (GLOBE NEWSWIRE ... following its 2025 American Society of Clinical Oncology (ASCO) Oral Presentation in Chicago, IL. The virtual KOL event will take place ...

today announced new data from the Phase I/II GOBLET clinical trial in a poster presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. The presentation highlights ...

The data will be shared during a rapid oral presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place in Chicago from May 30 to June 3, 2025. TG4050 is a viral ...

The next steps will involve constructing parts such as valves, blood vessels and a mini ... positioned with a highest precision for it to function properly. From arranging the thousands of ...

FLORENCE, Italy and NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- The Menarini Group (“Menarini ... These data will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.